Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Weber

Showing results (171-180 of 221) with videos related to

Pageof 23
Sort By:
Iscience|July 18, 2024
Association between bilirubin and biomarkers of metabolic health and oxidative stress in the MARK-AGE cohortVanessa Schoissengeier, Lina Maqboul, Daniela Weber, et al.
Nature Communications|May 4, 2019
Clonal evolution patterns in acute myeloid leukemia with NPM1 mutationSibylle Cocciardi, Anna Dolnik, Silke Kapp-Schwoerer, et al.
Nutrients|December 11, 2019
Nutritional Factors Modulating Alu Methylation in an Italian Sample from The Mark-Age Study Including Offspring of Healthy NonagenariansRobertina Giacconi, Marco Malavolta, Alexander Bürkle, et al.
Blood Advances|December 22, 2020
Genomic heterogeneity in core-binding factor acute myeloid leukemia and its clinical implicationNikolaus Jahn, Tobias Terzer, Eric Sträng, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|May 13, 2021
Age, Sex, and BMI Influence on Copper, Zinc, and Their Major Serum Carrier Proteins in a Large European Population Including Nonagenarian Offspring From MARK-AGE StudyFrancesco Piacenza, Robertina Giacconi, Laura Costarelli, et al.
Haematologica|April 3, 2016
Salvage therapy with high-dose cytarabine and mitoxantrone in combination with all-trans retinoic acid and gemtuzumab ozogamicin in acute myeloid leukemia refractory to first induction therapyMarie-Luise Hütter-Krönke, Axel Benner, Konstanze Döhner, et al.
Hemasphere|July 16, 2024
Refinement of the prognostic impact of somatic <i>CEBPA</i> bZIP domain mutations in acute myeloid leukemia: Results of the AML Study Group (AMLSG)Frank G Rücker, Andrea Corbacioglu, Julia Krzykalla, et al.
Annals of Hematology|October 4, 2016
All-trans retinoic acid as adjunct to intensive treatment in younger adult patients with acute myeloid leukemia: results of the randomized AMLSG 07-04 studyRichard F Schlenk, Michael Lübbert, Axel Benner, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|October 19, 2017
Zinc-Induced Metallothionein in Centenarian Offspring From a Large European Population: The MARK-AGE ProjectRobertina Giacconi, Laura Costarelli, Francesco Piacenza, et al.
Leukemia|August 30, 2019
Functional and clinical characterization of the alternatively spliced isoform AML1-ETO9a in adult patients with translocation t(8;21)(q22;q22.1) acute myeloid leukemia (AML)Mridul Agrawal, Peggy Schwarz, Benedetto Daniele Giaimo, et al.
Pageof 23

Showing results (171-180 of 221) with videos related to

Sort By:
Pageof 23
Iscience|July 18, 2024
Association between bilirubin and biomarkers of metabolic health and oxidative stress in the MARK-AGE cohortVanessa Schoissengeier, Lina Maqboul, Daniela Weber, et al.
Nature Communications|May 4, 2019
Clonal evolution patterns in acute myeloid leukemia with NPM1 mutationSibylle Cocciardi, Anna Dolnik, Silke Kapp-Schwoerer, et al.
Nutrients|December 11, 2019
Nutritional Factors Modulating Alu Methylation in an Italian Sample from The Mark-Age Study Including Offspring of Healthy NonagenariansRobertina Giacconi, Marco Malavolta, Alexander Bürkle, et al.
Blood Advances|December 22, 2020
Genomic heterogeneity in core-binding factor acute myeloid leukemia and its clinical implicationNikolaus Jahn, Tobias Terzer, Eric Sträng, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|May 13, 2021
Age, Sex, and BMI Influence on Copper, Zinc, and Their Major Serum Carrier Proteins in a Large European Population Including Nonagenarian Offspring From MARK-AGE StudyFrancesco Piacenza, Robertina Giacconi, Laura Costarelli, et al.
Haematologica|April 3, 2016
Salvage therapy with high-dose cytarabine and mitoxantrone in combination with all-trans retinoic acid and gemtuzumab ozogamicin in acute myeloid leukemia refractory to first induction therapyMarie-Luise Hütter-Krönke, Axel Benner, Konstanze Döhner, et al.
Hemasphere|July 16, 2024
Refinement of the prognostic impact of somatic <i>CEBPA</i> bZIP domain mutations in acute myeloid leukemia: Results of the AML Study Group (AMLSG)Frank G Rücker, Andrea Corbacioglu, Julia Krzykalla, et al.
Annals of Hematology|October 4, 2016
All-trans retinoic acid as adjunct to intensive treatment in younger adult patients with acute myeloid leukemia: results of the randomized AMLSG 07-04 studyRichard F Schlenk, Michael Lübbert, Axel Benner, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|October 19, 2017
Zinc-Induced Metallothionein in Centenarian Offspring From a Large European Population: The MARK-AGE ProjectRobertina Giacconi, Laura Costarelli, Francesco Piacenza, et al.
Leukemia|August 30, 2019
Functional and clinical characterization of the alternatively spliced isoform AML1-ETO9a in adult patients with translocation t(8;21)(q22;q22.1) acute myeloid leukemia (AML)Mridul Agrawal, Peggy Schwarz, Benedetto Daniele Giaimo, et al.
Pageof 23